On January 16, 2024 Bio-Techne Corporation (NASDAQ: TECH) reported that management will host a conference call and webcast on Thursday, February 1, 2024, at 8:00 a.m. CST to review second quarter fiscal 2024 financial results (Press release, Bio-Techne, JAN 16, 2024, https://investors.bio-techne.com/news/detail/401/bio-techne-to-host-conference-call-on-february-1-2024-to-announce-second-quarter-fiscal-2024-financial-results [SID1234639252]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Access to the discussion may be obtained as follows:
Time:
8:00 a.m. CST
Date:
February 1, 2024
Dial-in:
1-877-407-9208 or 1-201-493-6784 (for international callers)
Conference ID:
13743935
Webcast:
A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 13743935.
The replay will be available from 11:00 a.m. CST on Thursday, February 1, 2024, until 11:00 p.m. CST on Friday, March 1, 2024.